Filtered By:
Condition: Heart Attack
Management: Insurance
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 515 results found since Jan 2013.
Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study
Conclusions Using large Korean cohort data, our study proved incrementally elevated cardiovascular risk and clinical benefit associated with LDL-C<100 mg/dL in individuals with severe hypercholesterolemia. These results support aggressive lipid lowering and provide evidence for the LDL-C target in this population.PMID:35470675 | DOI:10.1161/JAHA.121.024379
Source: Atherosclerosis - April 26, 2022 Category: Cardiology Authors: Chan Joo Lee Sanghyun Park Kyungdo Han Sang-Hak Lee Source Type: research
Early rhythm control and the risks of ischaemic stroke, heart failure, mortality and adverse events when performed early ( & lt;3 months)
CONCLUSIONS: Early rhythm control, especially when performed earlier (<3months), was associated with a lower risk of adverse events than usual care among patients with early AF.PMID:35322396 | DOI:10.1055/a-1807-0336
Source: Thrombosis and Haemostasis - March 24, 2022 Category: Hematology Authors: Tze-Fan Chao Yi-Hsin Chan Chern-En Chiang Ta-Chuan Tuan Jo-Nan Liao Tzeng-Ji Chen Gregory Yh Lip Shih-Ann Chen Source Type: research
Impact of Individual Income Level on Late Mortality After Coronary Artery Bypass Grafting
CONCLUSIONS: Patients with a lower individual income level had an increased risk of the poorer long-term outcomes after CABG as compared with the highest individual income level quartile.PMID:35305990 | DOI:10.1016/j.athoracsur.2022.02.055
Source: The Annals of Thoracic Surgery - March 20, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Jun Ho Lee Yongil Cho Yun Jin Kim Yang Hyun Cho Yong Ho Jeong Hyo Jun Jang Sun Kyun Ro Hyuck Kim Source Type: research
Incidence of newly diagnosed diabetes after Covid-19
Conclusions/interpretationCovid-19 confers an increased risk for type 2 diabetes. If confirmed, these results support the active monitoring of glucose dysregulation after recovery from mild forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Graphical abstract
Source: Diabetologia - March 16, 2022 Category: Endocrinology Source Type: research
JAK2V617F Is a Risk Factor for TIA/Stroke in Young Patients
The objective of this study was to assess the risk of arterial thrombosis in patients who harbor the JAK2V617F allele burden ≥1% detected during workup for myeloproliferative neoplasms (MPNs). We conducted a large cross-sectional analysis consisted of 5,220 patients who were tested for JAK2V617F and 1,047,258 people matched in age from health care insurance provider, taking into account age, sex, hypertension, diabetes, atrial fibrillation. Compared with noncarriers, mutation carriers were older, less likely to be current or past smokers and had lower body mass index. There was no significant difference between the group...
Source: Thrombosis and Haemostasis - March 15, 2022 Category: Hematology Authors: Tamar Shapira Cohen Gabriel Chodick David M Steinberg Ehud Grossman Mordechai Shohat Ophira Salomon Source Type: research
A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea
CONCLUSION: The 10-year SR of IPAH was 57% in Korea. The HR for IPAH was significantly high in patients with older age and other risk factors.PMID:35289139 | DOI:10.3346/jkms.2022.37.e80
Source: J Korean Med Sci - March 15, 2022 Category: General Medicine Authors: Shin Yi Jang Eun Kyoung Kim June Huh Jinyoung Song I-Seok Kang Seung Woo Park Duk-Kyung Kim Sung-A Chang Source Type: research
JAK2V617F Is a Risk Factor for TIA/Stroke in Young Patients
The objective of this study was to assess the risk of arterial thrombosis in patients who harbor the JAK2V617F allele burden ≥1% detected during workup for myeloproliferative neoplasms (MPNs). We conducted a large cross-sectional analysis consisted of 5,220 patients who were tested for JAK2V617F and 1,047,258 people matched in age from health care insurance provider, taking into account age, sex, hypertension, diabetes, atrial fibrillation. Compared with noncarriers, mutation carriers were older, less likely to be current or past smokers and had lower body mass index. There was no significant difference between the group...
Source: Thrombosis and Haemostasis - March 15, 2022 Category: Hematology Authors: Tamar Shapira Cohen Gabriel Chodick David M Steinberg Ehud Grossman Mordechai Shohat Ophira Salomon Source Type: research
